; (D) the criteria for defining the ISS as a research success; (E) the criteria used to determine whether the ISS is meeting the objective under section 301(b)(2) of the National Aeronautics and Space Administration Transition Authorization Act of 2017 ; (F) an assessment of whether the criteria under subparagraphs (D) and (E) are consistent with the research areas defined in, and recommendations and schedules under, the current National Academies of Sciences, Engineering, and Medicine Decadal Survey on Biological and Physical Sciences in Space; (G) any necessary contributions that ISS extension would make to enabling execution of the human exploration roadmap under section 432 of the National Aeronautics and Space Administration Transition Authorization Act of 2017 ; (H) the cost estimates for operating the ISS to achieve the criteria required under subparagraphs (D) and (E) and the contributions identified under subparagraph (G); (I) the cost estimates for extending operations of the ISS to 2024, 2028, and 2030; (J) an evaluation of the feasible and preferred service life of the ISS beyond the period described in section 503 of the National Aeronautics and Space Administration Authorization Act of 2010 ( 42 U.S.C. 18353 ), through at least 2028, as a unique scientific, commercial, and space exploration-related facility, including— (i) a general discussion of international partner capabilities and prospects for extending the partnership; (ii) the cost associated with extending the service life; (iii) an assessment on the technical limiting factors of the service life of the ISS, including a list of critical components and their expected service life and availability; and (iv) such other information as may be necessary to fully describe the justification for and feasibility of extending the service life of the ISS, including the potential scientific or technological benefits to the Federal Government, public, or to academic or commercial entities